持续性血尿与IgA肾病进展:队列研究
该回顾性队列研究纳入1333例中国IgA肾病患者,中位随访45个月,发现随访期间时间变化的血尿水平是复合肾脏进展事件的独立危险因素(HR 1.46),而诊断后6个月内血尿缓解与复合事件风险降低显著相关(HR 0.41),且在持续性蛋白尿亚组中同样显著。
要点
- 时间变化的血尿水平是IgA肾病进展的独立危险因素。
- 诊断后6个月内血尿缓解与肾脏进展风险降低显著相关。
- 自动化尿沉渣检测与人工镜检结果高度一致,可替代人工评估。
核心结论
- 血尿水平与IgA肾病肾脏进展独立相关,血尿缓解与持续性蛋白尿患者的肾脏结局改善相关。
- 自动化方法评估血尿有望替代人工尿沉渣镜检用于监测IgA肾病进展。
研究设计与样本
- 回顾性队列研究,纳入中国转诊医院1333例IgA肾病患者,中位随访45个月。
主要发现
- 随访期间时间变化的血尿是复合肾脏进展事件的独立危险因素(HR 1.46;95% CI 1.13-1.87;P=0.003)。
- 诊断后6个月内血尿缓解与复合肾脏进展事件风险显著降低相关(HR 0.41;95% CI 0.28-0.61;P<0.001)。
- 前6个月蛋白尿缓解与血尿缓解之间存在显著交互作用(P<0.001)。
- 在持续性蛋白尿(前6个月蛋白排泄>1.0 g/d)亚组中,血尿缓解与肾脏进展的关联可检测到(HR 0.46;95% CI 0.32-0.68),而在蛋白尿已缓解的患者中未观察到(HR 0.64;95% CI 0.31-1.29;P=0.2)。
- 两种血尿评估技术呈强且显著的线性相关(r=0.948;P<0.001),且结果一致。
关键数值与推荐
- 血尿缓解定义:随访前6个月内平均红细胞计数≤5/高倍视野(人工法)或≤28红细胞/μL(自动化法)。
- 复合肾脏进展事件定义:eGFR下降50%或发生肾衰竭。
临床怎么用
- 在IgA肾病随访中应动态监测血尿水平,血尿持续不缓解提示肾脏进展风险较高。
- 对于持续性蛋白尿患者,血尿缓解与更好的肾脏结局相关,可作为治疗反应的监测指标。
- 自动化尿沉渣分析可用于血尿评估,与人工镜检结果高度一致。
局限性
- 单中心回顾性研究。
- 采用含时间变化协变量的比例风险回归可能产生时间变化混杂。
- 未直接评估血尿降低的预测价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Hematuria is the most typical presentation of immunoglobulin A nephropathy (IgAN); however, its role in disease progression is still controversial. This study aimed to evaluate the association of hematuria and progression of IgAN. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: A cohort of 1,333 patients with IgAN treated at a Chinese referral hospital with a median follow-up of 45 months. PREDICTORS: Microhematuria was evaluated in fresh urine using a fully automated urine particle analyzer (automated method) and urine sediment examination by a skilled examiner (manual method). Hematuria was characterized as a time-varying attribute; namely, average hematuria level was calculated for every 6-month period for each patient during follow-up. Remission was defined as average red blood cell count ≤5/high-power field (manual method) or ≤28 red blood cells/μL (automated method) during the first 6 months of follow-up. OUTCOMES: Composite event of 50% decline in estimated glomerular filtration rate or development of kidney failure. ANALYTICAL APPROACH: Multivariable cause-specific hazards models to analyze the relationship between hematuria and the composite kidney disease progression event. RESULTS: Time-varying hematuria during follow-up was an independent risk factor for the composite kidney disease progression event (HR, 1.46; 95% CI, 1.13-1.87; P = 0.003). Hematuria remission during the 6 months after diagnosis was associated with a significantly lower rate of the composite kidney disease progression event (HR, 0.41; 95% CI, 0.28-0.61; P < 0.001). A significant interaction was detected between remission of proteinuria and remission of hematuria during the first 6 months (P < 0.001). The association between remission of hematuria and kidney disease progression was detectable (HR, 0.46; 95% CI, 0.32-0.68) within the subpopulation with persistent proteinuria (protein excretion > 1.0 g/d during the first 6 months), but not among patients whose proteinuria had remitted (HR, 0.64; 95% CI, 0.31-1.29; P = 0.2). The 2 techniques for hematuria evaluation were strongly and significantly linearly correlated (r = 0.948; P < 0.001), and results using these 2 methods were consistent. LIMITATIONS: A single-center retrospective study. Proportional hazards regression incorporating time-varying covariates may create time-varying confounding. The predictive value of reductions in hematuria was not directly evaluated. CONCLUSIONS: Level of hematuria was independently associated with kidney disease progression, whereas hematuria remission was associated with improved kidney outcomes in IgAN among patients with persistent proteinuria. Additionally, to monitor IgAN progression, automated methods to evaluate hematuria hold promise as a replacement for manual evaluation of urinary sediment.
引用
- Yu GZ, Guo L, Dong JF, et al. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study. Am J Kidney Dis. 2020. PMID: 32197881. doi:10.1053/j.ajkd.2019.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。